PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaAll Plans · Coverage · Medical Policy · Pulmonology, Physical Therapy, NeurologyMedium impact

Chest Physiotherapy and Airway Clearance Devices (CPB 0067, reviewed 2026-03-18)

Effective date
Not stated in the notice
Identified
Aug 15, 2026

Summary

Aetna considers chest physiotherapy by a respiratory therapist medically necessary at the initial home prescription, to stabilize the member and train family members or caregivers, and when the member's pulmonary condition is unstable. Aetna considers airway oscillating devices, mechanical percussors, PEP masks and postural drainage boards medically necessary for listed conditions such as cystic fibrosis, chronic bronchitis, bronchiectasis, immotile cilia syndrome, asthma and COPD. High-frequency chest compression systems and mechanical in-exsufflation devices are considered medically necessary only for the specific neuromuscular, bronchiectasis, cystic fibrosis, immotile cilia and lung transplant criteria in the policy, and the Intrapulmonary percussive ventilator, BiWaze Clear System, Volara OLE device, Simeox device and high-frequency chest compression for other indications are considered experimental, investigational or unproven.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 6 steps
01Billing team: Bill chest physiotherapy by a respiratory therapist (CPT 94667, 94668, 94669, 97124 and HCPCS G0237, G0238) only when the policy criteria are met: the initial home prescription to stabilize the member and train family members or caregivers, or when the member's pulmonary condition is unstable.
02Chest physiotherapy for a member whose pulmonary condition is stable is not considered medically necessary.
03For high-frequency chest compression vests (HCPCS A7025, A7026, E0483), document a well documented failure of standard treatments to mobilize retained secretions and one of the listed indications, such as bronchiectasis confirmed by CT scan, cystic fibrosis, immotile cilia syndrome, a listed neuromuscular diagnosis, or lung transplant within the first 6 months post-operatively.
04For mechanical in-exsufflation devices (HCPCS A7020, E0482), document a neuromuscular disease causing a significant impairment of chest wall and/or diaphragmatic movement and failure of standard treatments such as chest percussion and postural drainage.
05For airway oscillating devices (HCPCS S8185), mechanical percussors (HCPCS E0480), PEP masks (HCPCS E0484) and postural drainage boards (HCPCS E0606), bill only for the diagnoses listed in the policy.
06The policy lists HCPCS E0481 (intrapulmonary percussive ventilator) and HCPCS A7021 and E0469 (BiWaze Clear System and Volara OLE device) as not covered for the indications listed in the policy.

Codes mentioned

94667946689466997124G0237G0238S8185E0480E0484E0606A7025A7026E0483A7020E0482E0481A7021E0469

Original notice

Chest Physiotherapy and Airway Clearance Devices (CPB 0067, reviewed 2026-03-18)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account